Clinical Investigation

Characteristics and outcomes of in vitro fertilization in different phenotypes of polycystic ovary syndrome

• Selçuk Selçuk
• Enis Özkaya
• Ahmet Eser
• Melda Kuyucu
• Hüseyin Tayfun Kutlu
• Belgin Devranoglu
• Kenan Sofuoglu
• Vedat Erkan Dayicioglu

The relationship between Polycystic ovary syndrome and vitamin D levels

• Setenay Arzu Yılmaz
• Sündüz Özlem Altınkaya
• Ayşegül Kebabçılar
• Özlem Seçilmiş Kerimoğlu
• Aybike Tazegül Pekin
• Sedat Abuşoğlu
• Çetin Çelik
• Ali Ünlü

The measurement of urinary 8-hidroxy-2'deoxyguanosine level with liquid chromatography-tandem mass spectrometry method in patients with polycystic ovary syndrome

• Şeyda Özdemir
• Özhan Özdemir
• Sevilay Sezer
• Oya Torun
• Hüseyin Tuğrul Çelik
• Ramazan Soydaş
• Cemal Atalay
• Muhittin Serdar
• Metin Yıldırımkaya

Role of osteocalcin, tumor necrosis factor-alpha and adiponectin in polycystic ovary syndrome patients with insulin resistance

• Gönül Erkan
• Ahter Tanay Tayyar
• Gökhan Açmaz
• Iptisam Ipek Müderris
• Gülden Baskol
• Fahri Bayram

Is anti-Mullerian hormone a good diagnostic marker for adolescent and young adult patients with Polycystic ovary syndrome?

• Aytekin Tokmak
• Hakan Timur
• Rıfat Taner Aksoy
• Mehmet Çınar
• Nafiye Yılmaz

Clinical Investigation

DLK1 and Nesfatin-1 levels and the relationship with metabolic parameters in polycystic ovary syndrome: Prospective, controlled study

• Melike Demir Çaltekin
• Ayşen Caniklioğlu
• Serenat Eris Yalçın
• Demet Aydoğan Kırmızı
• Emre Baser
• Ethem Serdar Yalvaç

Correlation of serum leptin and ghrelin levels with endocrine and reproductive parameters in women with clomiphene citrate resistant polycystic ovary syndrome

• Arzu Yurci
• Nur Dokuzeylül Güngör
• Kağan Güngör
• Şafak Hatırnaz

Effects of vitamin D supplementation on follicular development, gonadotropins and sex hormone concentrations, and insulin resistance in induced polycystic ovary syndrome

• Nasim Behmanesh
• Ali Abedelahi
• Hojjatollah Nozad Charoudeh
• Alireza Alihemmati

Serum sclerostin level and its relation to subclinical atherosclerosis in the polycystic ovary syndrome phenotypes: A prospective controlled study

• Feyza Nur İncesu Çintesun
• Ümmügülsüm Can
• Ersin Çintesun
• Ayşegül Altunkeser
• Aybike Kaya
• Oğuzhan Günenç

Does polycystic ovary syndrome with phenotype D affect the cardiovascular endurance, core endurance, body awareness, and the quality of life? A prospective, controlled study

• Hanife Doğan
• Melike Demir Çaltekin

Relationship between the follicular distribution pattern of polycystic ovaries and the degree of menstrual disturbance and serum sex steroid levels

• Ginevra Mills
• Bernice Goorah
• Shai E Elizur
• Weon-Young Son
• Michael H Dahan

The prevalence of uterine anomalies in infertile patients with polycystic ovary syndrome: A retrospective study in a tertiary center in Southeastern Turkey

• Serhat Ege
• Nurullah Peker
• Muhammed Hanifi Bademkıran

The role of inflammation, oxidation and Cystatin-C in the pathophysiology of polycystic ovary syndrome

• Özden Özdemir Başer
• Ayşe Yeşim Göçmen
• Demet Aydoğan Kırmızı

Clinical Investigation

Circulating SCUBE1 levels in women with polycystic ovary syndrome

• Onur Erol
• Hamit Yaşar Ellidağ
• Mustafa Kemal Özel
• Aysel Uysal Derbent
• Esin Eren
• Necat Yılmaz

Review

Are women with polycystic ovary syndrome more vulnerable to COVID-19 infection?

• Berna Dilbaz

Other

Association Between Plasma Adrenomedullin Levels and Bone Mineral Density in Patients with Polycystic Ovary Syndrome

• Banu Uçar
• Volkan Noyan
• Aykan Yücel
• Nevin Sagsöz
• Osman Çaglayan